Vyriad
MN - Rochester
BiotechnologyFocus: Immunovirotherapy
Vyriad is a life sciences company focused on Immunovirotherapy.
Oncology
Funding Stage
PRIVATE
Employees
51-200
Open Jobs
0
Pipeline & Clinical Trials
VSV-IFNβ-NIS
Malignant Solid TumourClinical Trials (1)
NCT02923466Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors
Phase 1Modified Measles Virus
Medulloblastoma, Childhood, RecurrentClinical Trials (1)
NCT02962167Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Phase 1Phase 1
Clinical Trials (1)
NCT02919449Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab
Phase 1MV-NIS
Urothelial CarcinomaClinical Trials (1)
NCT03171493Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy
Phase 1VSV-IFNβ-NIS
Solid TumorClinical Trials (1)
NCT03647163Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
Phase 1/2VV1
MelanomaOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials